The relationship in African-Americans of sex differences in insulin-mediated suppression of nonesterified fatty acids to sex differences in fasting triglyceride levels

Insulin is a potent antilipolytic hormone that promotes the deposition of fat and decreases the release of nonesterified fatty acids (NEFA) from adipose tissue. The purpose of this study was to investigate in African-Americans (AAs) sex differences in insulin-mediated suppression of plasma NEFA and...

Full description

Saved in:
Bibliographic Details
Published inMetabolism, clinical and experimental Vol. 46; no. 4; pp. 400 - 405
Main Authors Sumner, Anne E., Kushner, Harvey, Tulenko, Thomas N., Falkner, Bonita, Marsh, Julian B.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.1997
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Insulin is a potent antilipolytic hormone that promotes the deposition of fat and decreases the release of nonesterified fatty acids (NEFA) from adipose tissue. The purpose of this study was to investigate in African-Americans (AAs) sex differences in insulin-mediated suppression of plasma NEFA and fasting triglyceride (TG) levels. Ninety AAs, 44 men and 46 women with a mean age of 34 ± 8 years were classified by body mass index (BMI) into three groups: non-obese (22 men and 18 women), obese (12 men and 10 women), and severely obese (10 men and 18 women). In each BMI group, women versus men had greater percent body fat (non-obese, 30 ± 6 v 18 ± 6, P < .001; obese, 36 ± 3 v 26 ± 2, P < .001; and severely obese, 39 ± 4 v 29 ± 4, P < .001). An oral glucose tolerance test (OGTT) was performed with fasting TG levels and plasma insulin and NEFA concentrations obtained at 0, 30, 60, and 120 minutes. In women, insulin-mediated NEFA suppression was similar in each of the three BMI groups (non-obese, 85% ± 14%; obese, 88% ± 11%; and severely obese, 87% ± 10%; P = .8). In men, the percent suppression of NEFA declined with increasing obesity (non-obese, 83% ± 14%; obese, 71% ± 21%; and severely obese, 68% ± 16%; P = .04). Changes in NEFA suppression were reflected in the fasting TG levels. TG levels in women were similar in each BMI group (non-obese, 71 ± 39 mg/dL; obese; 69 ± 21; severely obese, 79 ± 30; P = .7). In contrast, fasting TG levels for men were higher in the higher BMI groups. Plasma TG levels in men were 87 ± 41 mg/dL for obese, 113 ± 65 for obese, and 169 ± 81 for severely obese ( P = .001). These data demonstrate sex differences in insulin-mediated NEFA metabolism. In AA women, the maintenance of sensitivity to insulin-mediated suppression of NEFA regardless of the degree of obesity may contribute to the normal plasma TG levels. For AA men, the resistance to insulin-mediated suppression of NEFA in the higher BMI categories may allow more NEFA to be released from adipose tissue into the circulation and available to the liver for synthesis into TG-containing lipoproteins.
Bibliography:S30
S
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0026-0495
1532-8600
DOI:10.1016/S0026-0495(97)90055-X